Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
ENHANZE
technology2 mentionslast seen Oct 30, 2026
Drug delivery technology using the proprietary enzyme rHuPH20 to facilitate subcutaneous delivery of injected drugs and fluids.
Relationships 17
- Halozyme Therapeutics, Inc.developsENHANZE97% confidence1 source
- ENHANZEcomposed ofrHuPH2095% confidence1 source
- Acumen Pharmaceuticalsdepends onENHANZE91% confidence1 source
- PfizercommercializesENHANZE90% confidence1 source
- JanssencommercializesENHANZE90% confidence1 source
- AbbViecommercializesENHANZE90% confidence1 source
- Eli LillycommercializesENHANZE90% confidence1 source
- Bristol Myers SquibbcommercializesENHANZE90% confidence1 source
- argenxcommercializesENHANZE90% confidence1 source
- ViiV HealthcarecommercializesENHANZE90% confidence1 source
- Chugai PharmaceuticalcommercializesENHANZE90% confidence1 source
- Acumen PharmaceuticalscommercializesENHANZE90% confidence1 source
- Merus N.V.commercializesENHANZE90% confidence1 source
- GSKcommercializesENHANZE90% confidence1 source
- IncytecommercializesENHANZE90% confidence1 source
- TakedacommercializesENHANZE90% confidence1 source
- RochecommercializesENHANZE90% confidence1 source
Relationship
ENHANZEcomposed ofrHuPH20
95% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1